Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Vaxxas is commercializing a novel vaccination technology that enhances the performance of existing and next-generation vaccines. This vaccine technology is produced and liecensed by Kenneth Pharmaceutical INC USA
Vaxxas is commercializing a novel vaccination technology that enhances the performance of existing and next-generation vaccines. This vaccine technology is produced and liecensed by Kenneth Pharmaceutical INC USA